Find company announcements below, or check out the latest news in the right side menu.
3. March 2011
In accordance with Section 28a of the Danish Securities Trading Act, Novozymes reports the following transactions under ISIN DK0010272129, Novozymes B shares under the symbol NZYM B.
2. March 2011
Novozymes has today announced the introduction of a new long-term share-based incentive program for Executive Management, to be implemented effective January 1, 2011.
Amendment of article 13.2: Retirement age of board members in the Articles of Association with new wording after the third full stop: “No one who has reached the age of 70 may be elected to the Board of Directors.
25. February 2011
On February 11, 2011, Novozymes initiated a share buyback program in accordance with the provisions of European Commission Regulation no. 2273/2003 of December 22, 2003, also referred to as the Safe Harbour Regulation.
18. February 2011
11. February 2011
On February 11, 2011, Novozymes has initiated a share buyback program in accordance with the provisions of European Commission Regulation no. 2273/2003 of December 22, 2003, also referred to as the Safe Harbour Regulation.
8. February 2011
In accordance with Section 28a of the Danish Securities Trading Act, Novozymes reports the following transactions under ISIN DK0010272129, Novozymes B shares under the symbol NZYM B
7. February 2011
In reference to company announcement no. 20 of December 20, 2010, the acquisition was subject to government approval and as the waiting period expired, the acquisition could be completed.
25. January 2011
21. January 2011
Sales and earnings grew strongly in 2010. Overall demand was high in the enzyme business, and costs were kept under control. For 2011, sales are expected to grow by 7–10% in DKK, local currency (LCY) and organically.
3. January 2011
In accordance with Section 28a of the Danish Securities Trading Act, Novozymes reports the following transaction under ISIN DK0010272129, Novozymes B shares under the symbol NZYM B.
20. December 2010
Novozymes A/S ("Novozymes") has today signed a definitive agreement to acquire EMD/Merck Crop BioScience Inc. ("EMD/Merck Crop BioScience") from Merck KGaA. The acquisition is subject to customary regulatory approvals and is expected to be completed between February and May 2011.
8. December 2010
Michael Munksøe has decided to terminate his employment with Novozymes and consequently resigns as employee elected board member in Novozymes A/S. Alternate Lars Bo Køppler joins the board of directors as new employee elected board member.
7. December 2010
6. December 2010
1. December 2010
29. November 2010
24. November 2010
29. October 2010
28. October 2010
Increased full-year 2010 expectations after strong 9M sales and earnings performance
20. September 2010
In accordance with with Section 28a of the Danish Securities Trading Act, Novozymes reports the following transactions under ISIN DK0010272129, Novozymes B shares under the symbol NZYM B.
14. September 2010
In accordance with Section 28a of the Danish Securities Tradiing Act, Novozymes reports the following transactions under ISIN DK0010272129, Novozymes B shares under the symbol NZYM B.
13. September 2010
10. September 2010
25. April 2013
1. April 2013
| Copyright © 2010 Novozymes. All Rights Reserved.